Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10699477rdf:typepubmed:Citationlld:pubmed
pubmed-article:10699477lifeskim:mentionsumls-concept:C1621958lld:lifeskim
pubmed-article:10699477pubmed:issue2lld:pubmed
pubmed-article:10699477pubmed:dateCreated2000-5-8lld:pubmed
pubmed-article:10699477pubmed:abstractTextTo compare conventional fractionation with hypofractionation in patients with a glioblastoma multiforme. Endpoints of the analysis are overall survival and palliative effect.lld:pubmed
pubmed-article:10699477pubmed:languageenglld:pubmed
pubmed-article:10699477pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10699477pubmed:citationSubsetIMlld:pubmed
pubmed-article:10699477pubmed:statusMEDLINElld:pubmed
pubmed-article:10699477pubmed:monthFeblld:pubmed
pubmed-article:10699477pubmed:issn0167-8140lld:pubmed
pubmed-article:10699477pubmed:authorpubmed-author:González...lld:pubmed
pubmed-article:10699477pubmed:authorpubmed-author:HulshofM CMClld:pubmed
pubmed-article:10699477pubmed:authorpubmed-author:Andries...lld:pubmed
pubmed-article:10699477pubmed:authorpubmed-author:SchimmelE CEClld:pubmed
pubmed-article:10699477pubmed:issnTypePrintlld:pubmed
pubmed-article:10699477pubmed:volume54lld:pubmed
pubmed-article:10699477pubmed:ownerNLMlld:pubmed
pubmed-article:10699477pubmed:authorsCompleteYlld:pubmed
pubmed-article:10699477pubmed:pagination143-8lld:pubmed
pubmed-article:10699477pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:meshHeadingpubmed-meshheading:10699477...lld:pubmed
pubmed-article:10699477pubmed:year2000lld:pubmed
pubmed-article:10699477pubmed:articleTitleHypofractionation in glioblastoma multiforme.lld:pubmed
pubmed-article:10699477pubmed:affiliationDepartment of Radiotherapy, Academic Medical Centre, University of Amsterdam, P.0. Box 22700, 1100 DE, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:10699477pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10699477pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10699477pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10699477pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10699477pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed